Ultragenyx Pharmaceutical | RARE - Market Capitalization


Ultragenyx Pharmaceutical reported $1.28B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.57B 100M Nov/2026
Agios Pharmaceuticals USD 1.61B 598M Nov/2026
Alnylam Pharmaceuticals USD 33.02B 7.17B Sep/2026
BioCryst Pharmaceuticals USD 2.54B 880M Jun/2026
BioMarin Pharmaceutical USD 10.68B 936M Nov/2026
Immunic USD 64M 23M Dec/2025
Insmed USD 24.93B 1.82B Sep/2026
Ionis Pharmaceuticals USD 4.52B 2.9B Nov/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
Kyowa Hakko Kirin JPY 1.33T 127.18B Nov/2026
MacroGenics USD 151M 143M Nov/2026
Moderna USD 99.14B 22.26B Nov/2026
Neurocrine Biosciences USD 16.38B 1.96B Nov/2026
Sarepta Therapeutics USD 1.65B 276M Nov/2026
Ultragenyx Pharmaceutical USD 1.37B 108M Nov/2026
Vertex Pharmaceuticals USD 140.44B 7.93B Nov/2026